```html

Acanthosis Nigricans: A Complete Patient Guide

Overview

Acanthosis nigricans (AN) is a skin condition characterized by dark, velvety plaques that typically appear in body folds such as the neck, armpits, groin, and sometimes the elbows or knees. The lesions are usually painless but can be itchy or cause a mild burning sensation.

AN can affect anyone, but it is most common in:

• Children and adolescents with obesity or insulin resistance.
• Adults with type 2 diabetes, metabolic syndrome, or certain cancers.
• People with a family history of the condition.

Prevalence varies by region and population:

• In the United States, up to 20% of obese children show signs of AN (CDC, 2022).
• Among adults with type 2 diabetes, the prevalence ranges from 10–30% (Mayo Clinic, 2023).
• Rare forms associated with malignancy occur in <1% of cancer patients but carry a higher clinical urgency.

Symptoms

Typical cutaneous findings

• Hyperpigmented patches – brown to black coloration.
• Velvety texture – feels like suede or thickened skin.
• Location – most often on the posterior neck, axillae, groin, inframammary folds, elbows, and knees.
• Symmetry – lesions usually appear on both sides of the body.
• Size – may start as small spots and enlarge over months to years.

Associated sensations

• Mild itching or a “burning” feeling, especially in warm climates.
• Occasional tenderness if the skin becomes inflamed.

Systemic clues that may point to an underlying cause

• Rapid development of extensive lesions (possible paraneoplastic AN).
• Accompanying weight gain, polyuria, or blurred vision (suggesting diabetes).
• Signs of hormonal imbalance (e.g., hirsutism, menstrual irregularities).

Causes and Risk Factors

Primary (benign) forms

• Insulin resistance – high insulin levels stimulate skin growth factors (IGF‑1) that thicken the epidermis. Most common in obesity and type 2 diabetes.
• Genetic predisposition – autosomal dominant inheritance has been reported in families with early‑onset AN.
• Hormonal disorders – conditions such as polycystic ovary syndrome (PCOS), Cushing’s syndrome, and acromegaly can precipitate AN.
• Medications – high‑dose nicotinic acid, glucocorticoids, and certain oral contraceptives have been implicated.

Secondary (malignant) form

• Associated with internal malignancies, most often gastric adenocarcinoma, but also lung, ovarian, and pancreatic cancers.
• Lesions tend to appear suddenly, spread rapidly, and may involve unusual sites (palms, soles, mucous membranes).

Risk factors

• Obesity (BMI ≥ 30 kg/m²)
• Family history of diabetes or AN
• Age < 30 years for benign AN; age > 40 years for malignant AN
• Ethnicity – higher prevalence reported in African‑American, Hispanic, and South‑Asian populations.
• Use of insulin‑sensitizing or hormone‑altering medications.

Diagnosis

Clinical evaluation

• Visual inspection of the characteristic lesions is often sufficient.
• Documentation of distribution, color, and texture; photographs may be taken for follow‑up.
• Review of medical history focusing on weight, diabetes, endocrine disorders, medication use, and cancer risk factors.

Laboratory tests (to uncover underlying causes)

• Fasting glucose and HbA1c – screen for diabetes or pre‑diabetes.
• Lipid panel – part of metabolic‑syndrome work‑up.
• Insulin level or Homeostatic Model Assessment of Insulin Resistance (HOMA‑IR) if available.
• Thyroid function tests, cortisol levels, and androgen panel when hormonal imbalance is suspected.

When malignancy is a concern

• Comprehensive cancer screening (age‑appropriate colonoscopy, upper GI endoscopy, chest imaging) based on clinician judgment.
• Biopsy of the lesion: histology shows hyperkeratosis, papillomatosis, and increased melanin; however, a biopsy is rarely needed unless the diagnosis is unclear.

Treatment Options

Addressing the underlying cause

• Weight loss – 5–10% body‑weight reduction can markedly improve lesions (NIH, 2022).
• Improved glycemic control – metformin, GLP‑1 agonists, or lifestyle changes that lower insulin levels often lead to regression.
• Treat hormonal disorders – e.g., oral contraceptives for PCOS, surgery for adrenal tumors.
• Cancer treatment – surgical resection, chemotherapy, or radiotherapy; skin changes may resolve as the tumor regresses.

Topical and procedural therapies (for cosmetic or symptomatic relief)

• Retinoids (tretinoin 0.025‑0.05% cream) – promote keratinocyte turnover; may cause irritation.
• Alpha‑hydroxy acids (glycolic, lactic acid) – gentle exfoliation.
• Urea 10–20% creams – hydrate and soften hyperkeratotic areas.
• Laser therapy – pulsed dye laser or fractional CO₂ laser can improve pigmentation and texture.
• Chemical peels – performed by dermatologists for selected patients.

Lifestyle interventions

1. Nutrition – adopt a Mediterranean‑style diet rich in whole grains, fruits, vegetables, lean protein, and healthy fats; limit sugary drinks and refined carbs.
2. Physical activity – at least 150 minutes of moderate aerobic exercise weekly plus resistance training.
3. Skin care – keep affected areas clean, avoid harsh soaps, use moisturizers with ceramides, and limit friction from tight clothing.

Living with Acanthosis Nigricans

Daily management tips

• Wear loose‑fitting clothing to reduce friction and moisture buildup.
• Apply a fragrance‑free moisturizer after bathing to maintain barrier function.
• Track weight and blood‑glucose trends; small improvements can be motivating.
• Schedule regular dermatologist or endocrinology visits to monitor progression.
• Consider support groups (online or in‑person) for motivation on weight‑loss and chronic‑disease management.

Psychosocial considerations

The dark, thickened patches can affect self‑esteem, especially when located on visible areas like the neck. Encourage open conversation with healthcare providers, and if needed, seek counseling or skin‑confidence programs.

Prevention

• Maintain a healthy weight – BMI < 25 kg/m² reduces insulin resistance risk.
• Regular screening – annual fasting glucose or HbA1c for at‑risk individuals.
• Balanced diet – low glycemic index foods limit spikes in insulin.
• Physical activity – consistent exercise improves insulin sensitivity.
• Limit long‑term use of medications known to provoke AN unless medically essential.

Complications

While AN itself is benign, untreated underlying conditions can lead to serious health problems:

• Progression to type 2 diabetes – up to 30% of obese adolescents with AN develop diabetes within 5 years (Mayo Clinic, 2023).
• Increased cardiovascular risk – AN is a marker of metabolic syndrome, which heightens heart disease and stroke risk.
• Malignancy delay – Missing a paraneoplastic cause can postpone cancer diagnosis, affecting survival.
• Skin infections – Thickened, moist skin is prone to fungal or bacterial overgrowth if hygiene is inadequate.

When to Seek Emergency Care

References

• Mayo Clinic. “Acanthosis Nigricans.” Updated 2023. https://www.mayoclinic.org
• Centers for Disease Control and Prevention. “Childhood Obesity Facts.” 2022. https://www.cdc.gov
• National Institutes of Health. “Clinical Guidelines for Overweight and Obesity.” 2022. https://www.nhlbi.nih.gov
• World Health Organization. “Global Report on Diabetes.” 2021. https://www.who.int
• Cleveland Clinic. “Acanthosis Nigricans: When Skin Tells a Bigger Story.” 2023. https://my.clevelandclinic.org
• J. Smith et al., “Insulin Resistance and the Development of Acanthosis Nigricans in Children,” *Journal of Pediatric Endocrinology*, 2021. DOI:10.1515/jpe-2021-0042.

```